Aspira Women’s Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM)

By Roger Burt | April 23, 2026

AUSTIN, TX / ACCESS Newswire / April 23, 2026 / Aspira Women’s Health Inc. (“Aspira”) (OTCQB:AWHL), an AI-enhanced bio-analytics company focused on the development of noninvasive gynecologic disease diagnostics and disease management tools, today announced it is completing the buildout of its molecular laboratory in Q2 2026, marking a major operational milestone that accelerates development and future commercialization…

Read More